Levosimendan Therapy for Low Ejection Fraction Takotsubo Syndrome

We are studying whether levosimendan can help improve heart function and reduce serious health risks in patients with Takotsubo syndrome. This trial compares the medication to a placebo to see if it makes a difference.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Glucosum Fresenius
Glucosum Fresenius is a sugar solution given into a vein to treat low blood sugar and provide quick energy.
Simdax
Simdax is a medicine used to help the heart pump more strongly in people with severe or suddenly worsening heart failure.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Glucose Monohydrate
Glucose monohydrate is a form of sugar used to provide quick energy and to raise low blood sugar levels.
Glucose Ph. Eur.
Glucose is a simple sugar used to provide energy and raise low blood sugar levels in healthcare settings.
Levosimendan
Levosimendan is a substance that increases heart muscle strength and widens blood vessels to improve blood flow in severe heart failure.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Cordenova
Dextrosa Fresenius Kabi
Dextrose

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Uniwersytecki Szpital Kliniczny W Bialymstoku
Klinika Kardiologii z OINK; Klinika Kardiologii Inwazyjnej z OIOK i Pracownia Hemodynamiki
Białystok, Poland
Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy
Klinika Kardiologii
Bydgoszcz, Poland
Górnośląskie Centrum Medyczne
II Oddział Kardiologii
Katowice, Poland

Sponsor: Medical University Of Gdansk
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.